| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
February 10, 2005 |
|
|
| |
|
|
| |
|
|
|
Cambridge Healthtech Institute, La Jolla, California
March 21 - 22
Glycomics, one of the newest additions to the ‘omics’ family has recently experienced a huge surge of interest in the biopharmaceutical industry. The recognition of the important role glycosylation is playing in biological functions has led to a significant increase in biopharmaceutical companies who focus their research on carbohydrate based drug development. Advanced technologies for analysis and synthesis result in better data about glycan structures, binding specifities and carbohydrate related genes. In addition, the number of carbohydrate related human diseases discovered is steadily increasing. New drugs are being developed in areas such as cancer treatment, angiogenesis, and vaccines.detailed agenda available at:
http://www.healthtech.com/2005/gly/index.asp
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
http://www.healthtech.com/2005/gly/index.asp
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
March 14 for poster presentations
|
|
|
|
|
|
|
|
Registration:
|
|
available online
|
|
|
E-mail:
|
|
meder@healthtech.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|